HealthCode Bio Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Series C
- Investors
-
3
HealthCode Bio General Information
Description
Developer of health assessment and disease diagnostic reagents and microchips, designed for modern biotechnological solutions. The company focuses on the development of human health assessment and disease diagnostic reagents and microchips, offering a macro bioinformatics testing, monitoring, and analysis system based on de novo protein technology, enabling the healthcare industry with biotech production.
Contact Information
Website
www.healthcodon.comCorporate Office
- 4th Floor, Building 2, No. 1233, Maoyuan Road
- Fengxian District
- Shanghai
- China
Corporate Office
- 4th Floor, Building 2, No. 1233, Maoyuan Road
- Fengxian District
- Shanghai
- China
HealthCode Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series C) | 25-Apr-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 22-Oct-2024 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 02-Apr-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 25-Oct-2023 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 28-May-2022 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 12-Jun-2018 | Completed | Generating Revenue |
HealthCode Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
HealthCode Bio Patents
HealthCode Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023232095-A1 | Oral spray formulation based on virus blocking agent, and use thereof | Inactive | 31-May-2022 | ||
| WO-2023232095-A9 | Oral spray formulation based on virus blocking agent, and use thereof | Inactive | 31-May-2022 |
HealthCode Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
HealthCode Bio Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Wuxi Industry Development Group | Government | Minority | ||
| Shanghai Huamin Investment Management | Growth/Expansion | Minority | ||
| Cathy Fortune Corporation | Corporation | Minority |
HealthCode Bio FAQs
-
When was HealthCode Bio founded?
HealthCode Bio was founded in 2015.
-
Where is HealthCode Bio headquartered?
HealthCode Bio is headquartered in Shanghai, China.
-
What is the size of HealthCode Bio?
HealthCode Bio has 29 total employees.
-
What industry is HealthCode Bio in?
HealthCode Bio’s primary industry is Diagnostic Equipment.
-
Is HealthCode Bio a private or public company?
HealthCode Bio is a Private company.
-
What is HealthCode Bio’s current revenue?
The current revenue for HealthCode Bio is .
-
Who are HealthCode Bio’s investors?
Wuxi Industry Development Group, Shanghai Huamin Investment Management, and Cathy Fortune Corporation have invested in HealthCode Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
